Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Other Comprehensive Income

v3.24.1
Consolidated Statements of Operations and Other Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenues, net $ 44,384 $ 122,647
Cost of revenues 28,145 51,993
Gross profit 16,239 70,654
Operating expenses:    
Diagnostic expenses 1,932 12,022
General and administration 34,502 34,385
Research and development 1,418 652
Total operating expenses 37,852 47,059
(Loss) income from operations (21,613) 23,595
Interest income, net 78 153
Interest expense (1,275) (764)
Change in fair value of investment securities 0 (76)
Other income 10 0
(Loss) income from operations before income taxes (22,800) 22,908
Income tax benefit (expense) 6,018 (4,445)
Loss (income) from operations after income taxes (16,782) 18,463
Other comprehensive (loss) income:    
Unrealized gain on marketable debt securities, net of taxes (1,057) 932
Total comprehensive (loss) income $ (17,839) $ 19,395
Earnings (loss) per share:    
Basic (in dollars per share) $ (0.98) $ 1.17
Diluted (in dollars per share) $ (0.98) $ 1.02
Weighted average common shares outstanding:    
Basic (in shares) 17,207 15,845
Diluted (in shares) 17,207 18,651